Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,041 DKK | +67.71% | +4.14% | +14.24% |
May. 15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
May. 15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
- Stock Market
- Equities
- GMAB Stock
- Stock
- Charts Genmab
- Static Chart